Skip to main content

Alzheimer Disease

Gaining Greater Insights on the Role of Genetics and Microglia and Alzheimer Disease: Gareth Howell, PhD


"By embracing genetic heterogeneity in mouse models, we can better replicate the complexity of human Alzheimer disease and improve our understanding of its mechanisms."


For Alzheimer disease (AD) and also many other neurodegenerative disorders, familial aggregation was already recognized as a salient feature decades before any of the underlying molecular genetic and biochemical properties were known. Over the years, genome-wide genotyping and second-generation sequencing technologies have drastically changed the approaches used to study these disorders. In addition, there is growing evidence to suggest that underlying genetics can significantly modify response to development of amyloid and tau pathology with age.

At the 2024 Alzheimer’s Association International Conference (AAIC), held July 28-August 1, in Philadelphia, Pennsylvania, researchers from the Jackson Laboratory in Florida presented data looking at how genetics can impact microglia function, and how these differences related to AD pathology, and ultimately, cognitive decline. To achieve this, the study authors introduced humanized amyloid-ß (with and without driver mutations) and MAPT sequences in 2 mouse strains, C57BL/6J (B6) and WSB/EiJ (WSB).

Although the analyses are ongoing, results showed that B6 and WSB mice that carried humanized amyloid-ß without mutations did not exhibit significant amyloid pathology at 10 months. In contrast, B6 and WSB mice that carried the Swedish-Arctic-Austrian mutations did show significant parenchymal deposition starting at 6 months of age, and WSB exhibited mature cerebral amyloid angiopathy.

Senior author Gareth Howell, PhD, believes there is benefits to utilizing diverse mouse models to study AD. During the meeting, Howell, a professor of neurology and the Diana Davis Spencer Foundation Chair at the Jackson Laboratory, sat down to discuss the research and its significance. He provided commentary on the growing knowledge of microglia and its impact on AD, and how genetic variations in microglia-linked genes increase disease susceptibility.

rexinoids, gene expression, glioblastoma, retinoid X receptors, RXRs, proliferation, apoptosis, differentiation, brain tumor, prognosis, molecular mechanisms, therapeutic strategies, protein-protein interactions, yeast two-hybrid system, functional networks, cancer biology, targeted therapy, human glioblastoma cells, cellular processes, novel therapies,

#Rexinoids, #GeneExpression, #Glioblastoma, #RetinoidXReceptors, #RXRs, #Proliferation, #Apoptosis, #Differentiation, #BrainTumor, #Prognosis, #MolecularMechanisms, #TherapeuticStrategies, #ProteinProteinInteractions, #YeastTwoHybridSystem, #FunctionalNetworks, #CancerBiology, #TargetedTherapy, #HumanGlioblastomaCells, #CellularProcesses, #NovelTherapies

International Conference on Genetics and Genomics of Diseases

Visit: genetics-conferences.healthcarek.com

Award Nomination: x-i.me/gennom1
Award registration: x-i.me/genreg2
Member Nomination: x-i.me/genmember
Member Registration: x-i.me/genreg1
For Enquiries: genetics@healthcarek.com


Get Connected Here
---------------------------------
---------------------------------

Pinterest: x-i.me/genpt
Twitter: x-i.me/gentw
Facebook: x-i.me/genfb
Instagram: x-i.me/genin
Youtube: x-i.me/genyt

Comments

Post a Comment

Popular posts from this blog

Fruitful innovation

Fruitful innovation: Transforming watermelon genetics with advanced base editors The development of new adenine base editors (ABE) and adenine-to-thymine/ guanine base editors (AKBE) is transforming watermelon genetic engineering. These innovative tools enable precise A:T-to-G and A:T-to-T base substitutions, allowing for targeted genetic modifications. The research highlights the efficiency of these editors in generating specific mutations, such as a flowerless phenotype in ClFT (Y84H) mutant plants. This advancement not only enhances the understanding of gene function but also significantly improves molecular breeding, paving the way for more efficient watermelon crop improvement. Traditional breeding methods for watermelon often face challenges in achieving desired genetic traits efficiently and accurately. While CRISPR/Cas9 has provided a powerful tool for genome editing, its precision and scope are sometimes limited. These limitations highlight the need for more advanced gene-e...
Post a Comment
Read more

Genetic factors with clinical trial stoppage

Genetic factors associated with reasons for clinical trial stoppage Many drug discovery projects are started but few progress fully through clinical trials to approval. Previous work has shown that human genetics support for the therapeutic hypothesis increases the chance of trial progression. Here, we applied natural language processing to classify the free-text reasons for 28,561 clinical trials that stopped before their endpoints were met. We then evaluated these classes in light of the underlying evidence for the therapeutic hypothesis and target properties. We found that trials are more likely to stop because of a lack of efficacy in the absence of strong genetic evidence from human populations or genetically modified animal models. Furthermore, certain trials are more likely to stop for safety reasons if the drug target gene is highly constrained in human populations and if the gene is broadly expressed across tissues. These results support the growing use of human genetics to ...
Post a Comment
Read more

Genetic Test

Genetic test eliminates progressive retinal atrophy in English shepherd dogs Researchers at the University of Cambridge recently published their findings in Genes after identifying the genetic mutation that is causing progressive retinal atrophy (PRA) in English shepherd dogs. PRA is a group of inherited diseases causing progressive degeneration of the light sensitive cells within the back of the eyes. When it comes to PRA in dogs, they are born with normal vision but by the age of 4-5 they go totally blind with no treatment. According to the release, by identifying the canines carrying this disease before they lose vision, this can be then used as a tool to guide breeding decisions to prevent the passing of the disease onto puppies.1 Historically, owners did not realize their dog had PRA until they were middle-aged, which means it could have been passed on to puppies if they had bred, making this a hard disease to control. “Once the dog’s eyesight starts to fail there’s no treatment ...
Post a Comment
Read more